FREQUENCY OF METABOLIC SYNDROME IN PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS PRESENTING AT A PUBLIC SECTOR TERTIARY CARE HOSPITAL OF LAHORE: A CROSS- SECTIONAL STUDY
DOI:
https://doi.org/10.59058/jaimc.v20i4.45Keywords:
Metabolic Syndrome, Systemic Lupus Erythematosus, DyslipidemiaAbstract
Background and Objective: Metabolic syndrome is characterized by central obesity, deranged lipid profile, high blood pressure and abnormally high levels of blood sugar. It is an independent risk factor for cardiovascular disease. Systemic Lupus Erythematosus (SLE) is an autoimmune disease that can affect joints, skin, brain, lungs, kidneys, and blood vessels. The extent to which metabolic syndrome is frequent in our population is less known. The objective of this study was to assess the frequency of metabolic syndrome amongst SLE patients.
Methods: This cross-sectional study was undertaken in a public sector tertiary care hospital of Lahore from February 2021 through August 2021, including 110 confirmed SLE cases. After institutional approval and taking an informed consent, blood pressure, fasting and random blood sugar levels and fasting lipid profile were measured. Central obesity was assessed using waist circumference. Data were transferred to SPSS 21 for descriptive and inferential analyses. Frequencies were determined using numbers and percentages.
Results: Of 110 SLE patients, 14 (12.3%) were males and 96 (87.7%) were females. Mean age of SLE patients was 42.9± 9.9 years. Mean BMI was 28.7±4.7 kg/m2. The frequency of metabolic syndrome in studied SLE patients was 37/110 (33.6%).
Conclusion: Systemic lupus erythematosus patients had abnormally high serum triglyceride and cholesterol levels, diabetes mellitus, central obesity, high levels of fasting plasma glucose and hypertension. Therefore, one-third of SLE patients may have metabolic syndrome in our population.
References
Von Feldt JM. Systemic lupus erythematosus. Recognizing its various presentations. Postgrad Med 1995;97(4):79, 83, 86 passim.
Thong B, Olsen NJ. Systemic lupus erythematosus diagnosis and management. Rheumatology (Oxford). 2017;56(suppl_1):i3-i13.
Fava A, Petri M. Systemic lupus erythematosus: Diagnosis and clinical management. J Autoimmun. 2019;96:1-13.
Molina Rios S, Rojas Martinez R, Estévez Ramirez GM, Medina YF. Systemic lupus erythematosus and antiphospholipid syndrome after COVID-19 vaccination. A case report. Mod Rheumatol Case Rep. 2022:rxac018.
Selvaraja M, Too CL, Tan LK, Koay BT, Abdullah M, Shah AM, et al. Human leucocyte antigens profiling in Malay female patients with systemic lupus erythematosus: are we the same or different? Lupus Sci Med. 2022;9(1):e000554.
Jin S, Zou H, Zhen J, Wang D, He L, Deng Z. [Study of polymorphisms of HLA class Ⅰ (-A, -B, -C) and class Ⅱ (DRB1, DQA1, DQB1, DPA1, DPB1) genes among ethnic Hans from Southern China]. Zhonghua Yi Xue Yi Chuan Xue Za Zhi. 2017;34(1):110-14.
Rasouli-Saravani A, Tahamoli-Roudsari A, Basiri Z, Babaei M, Fazaeli A, Roshanaei G, et al. Relevance of autoantibody profile with HLA-DRB1 and -DQB1 alleles in a group of Iranian systemic lupus erythematosus patients. Immunol Lett. 2021;237:11-16.
Selvaraja M, Chin VK, Abdullah M, Arip M, Amin-Nordin S. HLA-DRB1*04 as a risk allele to systemic lupus erythematosus and lupus nephritis in the Malay population of Malaysia. Front Med (Lausanne). 2021;7:598665.
Wang T, Wang H, Qiu L, Wu L, Ling H, Xue Y, et al. Association of HLA-DR1, HLA-DR13, and HLA-DR16 polymorphisms with systemic lupus erythematosus: A meta-analysis. J Immunol Res. 2022;2022:8140982.
Kim JW, Kim HA, Suh CH, Jung JY. Sex hormones affect the pathogenesis and clinical characteristics of systemic lupus erythematosus. Front Med (Lausanne). 2022;9:906475.
Nusbaum JS, Mirza I, Shum J, Freilich RW, Cohen RE, Pillinger MH, et al. Sex differences in systemic lupus erythematosus: epidemiology, clinical considerations, and disease pathogenesis. Mayo Clin Proc. 2020;95(2):384-94.
Al-Riyami N, Salman B, Al-Rashdi A, Al-Dughaishi T, Al-Haddabi R, Hassan B. Pregnancy outcomes in systemic lupus erythematosus women: A single tertiary centre experience. Sultan Qaboos Univ Med J. 2021;21(2):e244-52.
Losada-García A, Cortés-Ramírez SA, Cruz-Burgos M, Morales-Pacheco M, Cruz-Hernández CD, Gonzalez-Covarrubias V, et al. Hormone-related cancer and autoimmune diseases: a complex interplay to be discovered. Front Genet. 2022;12:673180.
Tayem MG, Shahin L, Shook J, Kesselman MM. A review of cardiac manifestations in patients with systemic lupus erythematosus and antiphospholipid syndrome with focus on endocarditis. Cureus. 2022;14(1):e21698.
Kim JY, Yi ES. Analysis of the relationship between physical activity and metabolic syndrome risk factors in adults with intellectual disabilities. J Exerc Rehabil. 2018;14(4):592-97.
Fahed G, Aoun L, Bou Zerdan M, Allam S, Bou Zerdan M, Bouferraa Y, et al. Metabolic syndrome: updates on pathophysiology and management in 2021. Int J Mol Sci. 2022;23(2):786.
Mok CC. Metabolic syndrome and systemic lupus erythematosus: the connection. Expert Rev Clin Immunol. 2019;15(7):765-75.
Gigante A, Iannazzo F, Navarini L, Sgariglia MC, Margiotta DPE, Vaiarello V, et al. Metabolic syndrome and adipokine levels in systemic lupus erythematosus and systemic sclerosis. Clin Rheumatol. 2021;40(10):4253-58.
Demir S, Erten G, Artım-Esen B, Şahinkaya Y, Pehlivan Ö, Alpay-Kanıtez N, et al. Increased serum leptin levels are associated with metabolic syndrome and carotid intima media thickness in premenopausal systemic lupus erythematosus patients without clinical atherosclerotic vascular events. Lupus. 2018;27(9):1509-16.
Medeiros MM, Xavier de Oliveira ÍM, Ribeiro ÁT. Prevalence of metabolic syndrome in a cohort of systemic lupus erythematosus patients from Northeastern Brazil: association with disease activity, nephritis, smoking, and age. Rheumatol Int. 2016;36(1):117-24.
Rabbani MA, Habib HB, Islam M, Ahmad B, Majid S, Saeed W, et al. Survival analysis and prognostic indicators of systemic lupus erythematosus in Pakistani patients. Lupus 2009;18(9):848-55.
Parker B, Urowitz MB, Gladman DD, Lunt M, Bae SC, Sanchez-Guerrero J, et al. Clinical associations of the metabolic syndrome in systemic lupus erythematosus: data from an international inception cohort. Ann Rheum Dis. 2013;72(8):1308-14.
Sabio JM, Zamora-Pasadas M, Jiménez-Jáimez J, Albadalejo F, Vargas-Hitos J, Rodríguez del Aguila MD, et al. Metabolic syndrome in patients with systemic lupus erythematosus from Southern Spain. Lupus. 2008;17(9):849-59.
Chung CP, Avalos I, Oeser A, Gebretsadik T, Shintani A, Raggi P, et al. High prevalence of the metabolic syndrome in patients with systemic lupus erythematosus: association with disease characteristics and cardiovascular risk factors. Ann Rheum Dis 2007;66:208–14.
Spindler BA, Lucero E, Berman A, Sueldo R, Berman H, Santana M, et al; SLE Study Group of the Argentinean Society of Rheumatology. Metabolic syndrome in Argentinean patients with systemic lupus erythematosus. Lupus. 2015;24(12):e3.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2023 Saima Nouman Khan, Ahmad Hassan, Amina Umer, Aneela Chaudhary, Sadia Salman, Muhammad Ijaz Bhatti, Shehryar Aamer
This work is licensed under a Creative Commons Attribution 4.0 International License.
The articles published in this journal come under creative commons licence Attribution 4.0 International (CC BY 4.0) which allows to copy and redistribute the material in any medium or format Adapt — remix, transform, and build upon the material for any purpose, even commercially under following terms.
-
Attribution — You must give appropriate credit, provide a link to the license, and indicate if changes were made. You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use.
- No additional restrictions — You may not apply legal terms or technological measures that legally restrict others from doing anything the license permits.
The editorial board of the Journal strives hard for the authenticity and accuracy of the material published in the Journal. However, findings and statements are views of the authors and do not necessarily represent views of the Editorial Board. Many software like (Google Maps, Google Earth, Biorender (free version)) restricts the free distribution of materials prepared using these softwares. Therefore, authors are strongly advised to check the license/copyright information of the software used to prepare maps/images. In case of publication of copyright material, the correction will be published in one of the subsequent issues of the Journal, and the authors will bear the printing cost.
